Galina A. Aleschkina
Galina A. Aleschkina has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Irina Yu. Mashkova
Moscow State University of Medicine and Dentistry named after А.I. Evdokimov of the Ministry of Healthcare of the Russian Federation, Моscow
3 shared publications - Leonid M. Bardenshteyn
Russian University of Medicine
3 shared publications - Natalya N. Osipova
Evdokimov Moscow State University of Medicine and Dentistry
3 shared publications Васюк Юрий Александрович
Российский университет медицины
2 shared publications- Anna V. Krikova
Smolensk State Medical University
1 shared publication Dmitriy V. Smirnov
1 shared publication
Latest Publications
- Open Access
- 8 September 2025
- Published by ECO-Vector LLC in Russian Medicine
- Vol. 31 (4) , 322-330
Affective disorders accompanied by cognitive disorders in inpatients with cardiovascular diseases: a clinical and pathopsychological study
BACKGROUND: The multimorbidity of affective, cognitive, and cardiovascular diseases is an urgent issue of the contemporary medicine due to their severity, resistance to therapy, social maladjustment, and low quality of life. Common pathogenetic mechanisms, including endothelial dysfunction and disorders of the frontal and subcortical connections, enhance these conditions, increasing the risks of dementia and mortality. AIM: To study the clinical and psychopathological structure of affective disorders and comorbid cognitive disorders in inpatients with cardiovascular diseases in various age groups. METHODS: An observational, single-center study was conducted from January 2023 to June 2024 at the University Clinic of the Russian University of Medicine. The study involved 121 patients with cardiovascular diseases and non-psychotic mental disorders, including 47 (38.8%) with comorbid affective and cognitive disorders. The patients were divided into three age groups, 45–59, 60–74, and 75–90 years. Clinical psychopathological and psychometric (Hospital Anxiety and Depression Scale, Montreal Cognitive Assessment) and neuropsychological methods (clock drawing test, Luria’s method) were used. Statistical analysis was performed using Fisher’s exact test and Student’s t-test. RESULTS: In 85.1% of patients, we detected organic emotional disorders, mainly with alarming symptoms. Significant differences in the clinical structure of affective disorders between the groups indicate age-related differences (p = 0.045). Cognitive disorders (visual and constructional praxis, attention, memory, abstract thinking) are associated with vascular changes and dysfunction of the frontal lobes. The Montreal Cognitive Assessment scores were in the range of 18–27; the average score in the 45–59 group (24.9 ± 0.3) was higher compared to the 60–74 (23.5 ± 0.2; p 0.05) and 75–90 groups (23.4 ± 0.3; p 0.05). Moderate cognitive disorders were detected in 55.3% of cases, severe cognitive disorders were detected in 19.2% of cases, and 25.5% of cases were within the normal range. Subjective cognitive complaints related to the risk of dementia were not confirmed by tests in 27.6% of cases. Attention and abstract thinking disorders increased with age (p 0.05); whereas speech disorders showed no significant differences (p 0.05). CONCLUSION: The study highlights the importance of early diagnosis and an interdisciplinary approach to multimorbid conditions and a qualitative analysis of the psychopathological and pathopsychological structure of affective and cognitive disorders in cardiovascular cases. The limitation is the small sample size, requiring further research on a larger sample of patients.
- 8 September 2025
- Published by ECO-Vector LLC in Russian Medicine
- Vol. 31 (4) , 322-330
Open AccessAffective disorders accompanied by cognitive disorders in inpatients with cardiovascular diseases: a clinical and pathopsychological study
BACKGROUND: The multimorbidity of affective, cognitive, and cardiovascular diseases is an urgent issue of the contemporary medicine due to their severity, resistance to therapy, social maladjustment, and low quality of life. Common pathogenetic mechanisms, including endothelial dysfunction and disorders of the frontal and subcortical connections, enhance these conditions, increasing the risks of dementia and mortality. AIM: To study the clinical and psychopathological structure of affective disorders and comorbid cognitive disorders in inpatients with cardiovascular diseases in various age groups. METHODS: An observational, single-center study was conducted from January 2023 to June 2024 at the University Clinic of the Russian University of Medicine. The study involved 121 patients with cardiovascular diseases and non-psychotic mental disorders, including 47 (38.8%) with comorbid affective and cognitive disorders. The patients were divided into three age groups, 45–59, 60–74, and 75–90 years. Clinical psychopathological and psychometric (Hospital Anxiety and Depression Scale, Montreal Cognitive Assessment) and neuropsychological methods (clock drawing test, Luria’s method) were used. Statistical analysis was performed using Fisher’s exact test and Student’s t-test. RESULTS: In 85.1% of patients, we detected organic emotional disorders, mainly with alarming symptoms. Significant differences in the clinical structure of affective disorders between the groups indicate age-related differences (p = 0.045). Cognitive disorders (visual and constructional praxis, attention, memory, abstract thinking) are associated with vascular changes and dysfunction of the frontal lobes. The Montreal Cognitive Assessment scores were in the range of 18–27; the average score in the 45–59 group (24.9 ± 0.3) was higher compared to the 60–74 (23.5 ± 0.2; p 0.05) and 75–90 groups (23.4 ± 0.3; p 0.05). Moderate cognitive disorders were detected in 55.3% of cases, severe cognitive disorders were detected in 19.2% of cases, and 25.5% of cases were within the normal range. Subjective cognitive complaints related to the risk of dementia were not confirmed by tests in 27.6% of cases. Attention and abstract thinking disorders increased with age (p 0.05); whereas speech disorders showed no significant differences (p 0.05). CONCLUSION: The study highlights the importance of early diagnosis and an interdisciplinary approach to multimorbid conditions and a qualitative analysis of the psychopathological and pathopsychological structure of affective and cognitive disorders in cardiovascular cases. The limitation is the small sample size, requiring further research on a larger sample of patients.
- 25 August 2024
- Published by ECO-Vector LLC in Russian Medicine
Affective disorders accompanied by cognitive impairment in patients with a cardiological profile: prevalence, multimorbidity, medical and social risk factors
Clinical and medico-social issues of affective pathology combined with cognitive impairment in cardiac patients are a serious problem of modern medicine. This multimorbidity is characterized by higher risks of social maladjustment, disability, concomitant health problems and mortality. Cognitive dysfunctions in affective pathology are of great clinical and social importance, but their initial manifestations in cardiac patients are still insufficiently diagnosed. This leads to missed opportunities for the prevention of cognitive deficits. This review presents epidemiological data, pathological mechanisms, biological and psychosocial problems of multimorbid connections of cardiovascular, affective and cognitive pathology. Full-text articles, fragments of monographs selected by keywords in the databases Scopus, Web of Science, Medline, RSCI, eLibrary.ru, disserCat.ru, Psychiatrist, Sciencedirect were used.
- 25 August 2024
- Published by ECO-Vector LLC in Russian Medicine
Affective disorders accompanied by cognitive impairment in patients with a cardiological profile: prevalence, multimorbidity, medical and social risk factors
Clinical and medico-social issues of affective pathology combined with cognitive impairment in cardiac patients are a serious problem of modern medicine. This multimorbidity is characterized by higher risks of social maladjustment, disability, concomitant health problems and mortality. Cognitive dysfunctions in affective pathology are of great clinical and social importance, but their initial manifestations in cardiac patients are still insufficiently diagnosed. This leads to missed opportunities for the prevention of cognitive deficits. This review presents epidemiological data, pathological mechanisms, biological and psychosocial problems of multimorbid connections of cardiovascular, affective and cognitive pathology. Full-text articles, fragments of monographs selected by keywords in the databases Scopus, Web of Science, Medline, RSCI, eLibrary.ru, disserCat.ru, Psychiatrist, Sciencedirect were used.
- Open Access
- 8 September 2023
- Published by ECO-Vector LLC in Russian Medicine
- Vol. 29 (4) , 255-264
Early detection of the risk of cognitive disorders
BACKGROUND: Cognitive disorders are a relevant problem in an aging population. Research shows a wide range of data on the prevalence of cognitive disorders in the general population. Thus, more studies on the prevalence of cognitive disorders and assessment of the risks of their development are necessary, which will determine the burden on the regional healthcare system. AIM: To examine the prevalence of cognitive impairment in an outpatient multidisciplinary clinic setting and determine the risk ratios for cognitive deficits in different age groups. MATERIALS AND METHODS: The Montreal Cognitive Assessment Scale was used in the screening of people aged 4590 years. RESULTS: Cognitive dysfunction was noted in 20.0% of patients in the group aged 4559 years, 33.1% in the group aged 6074 years, and 79.6% in the group aged 7590 years. The average results on the assessment of cognitive functions of persons aged 4559 (27.10.3) and 6074 (26.20.2) years corresponded to the norm, and the value in persons aged 7590 (23.60.3) years was below the norm. In groups aged 6074 and 7590 years, the prevalence of cognitive dysfunction was comparable between men and women. Cognitive impairments in men aged 4559 years were recorded 2.5 times more often than that in women. The risk of cognitive disorders in the second group (aged 6074 years) relative to that in the first group (aged 4559 years) is insignificant (relative risk [RR], 1.21). In the third group (aged 7590 years), the probability of cognitive disorders is significantly higher than that in the second group (RR=2.40) and nearly five times higher than that in the first group (RR=4.86). CONCLUSION: Sex- and age-stratified screening indicators for assessing cognitive functions and the RRs of developing cognitive disorders in older age groups make it possible to plan for diagnostic, therapeutic, and preventive measures in mental health.
- 8 September 2023
- Published by ECO-Vector LLC in Russian Medicine
- Vol. 29 (4) , 255-264
Open AccessEarly detection of the risk of cognitive disorders
BACKGROUND: Cognitive disorders are a relevant problem in an aging population. Research shows a wide range of data on the prevalence of cognitive disorders in the general population. Thus, more studies on the prevalence of cognitive disorders and assessment of the risks of their development are necessary, which will determine the burden on the regional healthcare system. AIM: To examine the prevalence of cognitive impairment in an outpatient multidisciplinary clinic setting and determine the risk ratios for cognitive deficits in different age groups. MATERIALS AND METHODS: The Montreal Cognitive Assessment Scale was used in the screening of people aged 4590 years. RESULTS: Cognitive dysfunction was noted in 20.0% of patients in the group aged 4559 years, 33.1% in the group aged 6074 years, and 79.6% in the group aged 7590 years. The average results on the assessment of cognitive functions of persons aged 4559 (27.10.3) and 6074 (26.20.2) years corresponded to the norm, and the value in persons aged 7590 (23.60.3) years was below the norm. In groups aged 6074 and 7590 years, the prevalence of cognitive dysfunction was comparable between men and women. Cognitive impairments in men aged 4559 years were recorded 2.5 times more often than that in women. The risk of cognitive disorders in the second group (aged 6074 years) relative to that in the first group (aged 4559 years) is insignificant (relative risk [RR], 1.21). In the third group (aged 7590 years), the probability of cognitive disorders is significantly higher than that in the second group (RR=2.40) and nearly five times higher than that in the first group (RR=4.86). CONCLUSION: Sex- and age-stratified screening indicators for assessing cognitive functions and the RRs of developing cognitive disorders in older age groups make it possible to plan for diagnostic, therapeutic, and preventive measures in mental health.
- 29 August 2022
- Published by ECO-Vector LLC in Russian Medicine
- Vol. 28 (2) , 161-166
A clinical case of type II bipolar affective disorder
This study presents a clinical case of bipolar affective disorder type II. Difficulties in differential diagnosis at the early disease stages are discussed. The considered clinical case reflects real psychiatric practice when the onset of the disease is identified in adolescence and associated with the impact of a traumatic situation. Disease manifestations are characterized by polymorphism and atypical affective symptoms, which require careful differential diagnosis, considering disorders of other nosological categories and pathological pubertal crisis. Early recognition of type II bipolar affective disorder is associated with difficulties in hypomanic episode identification that are not regarded by patients as painful in most cases and are not a reason for seeking psychiatric advice and care.
- 29 August 2022
- Published by ECO-Vector LLC in Russian Medicine
- Vol. 28 (2) , 161-166
A clinical case of type II bipolar affective disorder
This study presents a clinical case of bipolar affective disorder type II. Difficulties in differential diagnosis at the early disease stages are discussed. The considered clinical case reflects real psychiatric practice when the onset of the disease is identified in adolescence and associated with the impact of a traumatic situation. Disease manifestations are characterized by polymorphism and atypical affective symptoms, which require careful differential diagnosis, considering disorders of other nosological categories and pathological pubertal crisis. Early recognition of type II bipolar affective disorder is associated with difficulties in hypomanic episode identification that are not regarded by patients as painful in most cases and are not a reason for seeking psychiatric advice and care.
- Open Access
- 22 October 2021
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 20 (3) , 79-87-87
The structure of affective fluctuations in a non-clinical sample
Aim. To study the structure of mood fluctuations at the preclinical stage based on the findings of screening methods.Materials and methods. A total of 129 students participated in the study. The average age was 18.95 ± 0.08 years. We used the clinical and psychopathological method, the Mini-International Neuropsychiatric Interview (MINI), and screening methods, such as the diagnostic questionnaire for bipolar disorder (Hypomania Checklist-32 (HCL-32)), and Hamilton Depression Scale (HAMD-17).Results. Upon a clinical and psychopathological examination according to ICD-10 criteria, class V, mental and behavioral disorders (F00-F99), including affective pathology, were not detected. According to the findings of the HCL-32 screening technique, 61.2% (n = 79) of respondents had a cumulative score above the threshold. Analysis of individual items on the HCL-32 scale across the entire sample revealed that the majority of examinees positively assessed the impact of mood elevations on the family sphere (63.57%; n = 82), social activities (68.99%; n = 89), work (75.19%; n = 91), and recreational sphere (82.17%; n = 106). Positive (36.43%; n = 47; 95% confidence interval (CI) 28.13–44.74) and neutral (37.21%; n = 48; 95% CI 33.35–50.37) assessments of mood elevations were also detected by the respondents’ immediate circle, which, in general, significantly complicates recognition of hypomania symptoms and delays seeking specialized care. In the structure of mood elevation episodes irritability (r = –0.684), conflict (r = –0.665), risk-taking behavior (r = –0.550), increased sexual desire (r = 0.527), increased energy and activity (r = 0.431), distractibility (r = –0.467), stimulant use (r = –0.467), and decreased need for sleep (r = 0.408) dominated. These signs are very similar to the clinical manifestations of a hypomanic episode in bipolar II disorder.Signs of mild depression revealed according to the HAMD-17 scale in 34.8% (n = 45) of respondents included sleep disorders (r = 0.693), decreased ability to work (r = 0.520), depressive mood (r = 0.579), hypochondria (r = 0.466), general somatic symptoms (r = –0.508), and gastrointestinal disorders (r = 0.513). These signs did not result in chief complaints and were not the reason for seeking specialized care.Conclusion. In the non-clinical sample, in the structure of mood swings, mood elevations dominated, which were not subjectively identified as illness symptoms and did not appear as complaints in clinical and psychopathological examinations. Low mood was accompanied by general somatic symptoms, which may indicate subsequent formation of comorbid pathology. The identified subsyndromal signs of hypomania and depression in the nonclinical sample in the absence of complaints and psychiatric care-seeking are of clinical significance as predictors of a bipolar affective disorder and require further clinical and dynamic monitoring.
- 22 October 2021
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 20 (3) , 79-87-87
Open AccessThe structure of affective fluctuations in a non-clinical sample
Aim. To study the structure of mood fluctuations at the preclinical stage based on the findings of screening methods.Materials and methods. A total of 129 students participated in the study. The average age was 18.95 ± 0.08 years. We used the clinical and psychopathological method, the Mini-International Neuropsychiatric Interview (MINI), and screening methods, such as the diagnostic questionnaire for bipolar disorder (Hypomania Checklist-32 (HCL-32)), and Hamilton Depression Scale (HAMD-17).Results. Upon a clinical and psychopathological examination according to ICD-10 criteria, class V, mental and behavioral disorders (F00-F99), including affective pathology, were not detected. According to the findings of the HCL-32 screening technique, 61.2% (n = 79) of respondents had a cumulative score above the threshold. Analysis of individual items on the HCL-32 scale across the entire sample revealed that the majority of examinees positively assessed the impact of mood elevations on the family sphere (63.57%; n = 82), social activities (68.99%; n = 89), work (75.19%; n = 91), and recreational sphere (82.17%; n = 106). Positive (36.43%; n = 47; 95% confidence interval (CI) 28.13–44.74) and neutral (37.21%; n = 48; 95% CI 33.35–50.37) assessments of mood elevations were also detected by the respondents’ immediate circle, which, in general, significantly complicates recognition of hypomania symptoms and delays seeking specialized care. In the structure of mood elevation episodes irritability (r = –0.684), conflict (r = –0.665), risk-taking behavior (r = –0.550), increased sexual desire (r = 0.527), increased energy and activity (r = 0.431), distractibility (r = –0.467), stimulant use (r = –0.467), and decreased need for sleep (r = 0.408) dominated. These signs are very similar to the clinical manifestations of a hypomanic episode in bipolar II disorder.Signs of mild depression revealed according to the HAMD-17 scale in 34.8% (n = 45) of respondents included sleep disorders (r = 0.693), decreased ability to work (r = 0.520), depressive mood (r = 0.579), hypochondria (r = 0.466), general somatic symptoms (r = –0.508), and gastrointestinal disorders (r = 0.513). These signs did not result in chief complaints and were not the reason for seeking specialized care.Conclusion. In the non-clinical sample, in the structure of mood swings, mood elevations dominated, which were not subjectively identified as illness symptoms and did not appear as complaints in clinical and psychopathological examinations. Low mood was accompanied by general somatic symptoms, which may indicate subsequent formation of comorbid pathology. The identified subsyndromal signs of hypomania and depression in the nonclinical sample in the absence of complaints and psychiatric care-seeking are of clinical significance as predictors of a bipolar affective disorder and require further clinical and dynamic monitoring.